[Efficacy and safety of TNF inhibitors--results of randomized, controlled clinical trials vs long term observational studies]

Pol Arch Med Wewn. 2006 Oct;116(4):980-7.
[Article in Polish]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Adalimumab
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Controlled Clinical Trials as Topic*
  • Etanercept
  • Humans
  • Immunoglobulin G / therapeutic use
  • Infliximab
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Treatment Outcome
  • Tumor Necrosis Factor Inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor Inhibitors
  • Infliximab
  • Adalimumab
  • Etanercept